• March 14, 2017

    Klobuchar Calls For More Aggressive Merger Enforcement

    Senate Democrats’ top lawmaker on antitrust matters called on federal antitrust regulators Monday to step up their merger enforcement efforts and said she would introduce legislation to subject deals to increased scrutiny.

  • March 14, 2017

    Lawmakers Clear UK Gov't To Start Formal Brexit Talks

    British Parliament late Monday cleared the final hurdle for Britain's government to formally launch talks to leave the European Union, amid growing unease that future Brexit negotiations may not produce a deal giving U.K. banks and businesses free access to the EU single market.

  • March 13, 2017

    Veeva Countersuit Alleges IMS Monopoly Over Data Products

    Veeva Systems Inc. lodged a countersuit Monday against Quintiles IMS Inc. in New Jersey federal court alleging anticompetitive conduct over the offering of software products to life sciences companies, the same day it sought partial dismissal of IMS’ suit alleging Veeva misappropriated health care data trade secrets.

  • March 13, 2017

    Pharma Cos. Seek To Toss Blood Pressure Drug Antitrust Suit

    Mylan, Teva Pharmaceuticals and other generic-drug manufacturers on Friday slammed antitrust claims brought by drug buyers in New York federal court over an alleged conspiracy to jack up the price of generic blood pressure medication propranolol, arguing that the buyers haven’t plausibly shown there was a price-fixing conspiracy.

  • March 13, 2017

    Israeli Exec Pleads Guilty To DOJ Foreign Aid Fraud Charges

    A former executive of an Israel-based defense contractor pled guilty to several fraud charges in Connecticut federal court on Monday after prosecutors accused him of carrying out several schemes to defraud a U.S. foreign aid program, the DOJ announced on Monday.

  • March 13, 2017

    Feds Ask DC Circ. To Keep Anthem-Cigna Merger Blocked

    The U.S. Department of Justice urged the D.C. Circuit on Monday to uphold a decision blocking the proposed $54 billion Anthem-Cigna merger, arguing Anthem's claim the deal would save $2.4 billion in medical costs cannot be substantiated.

  • March 13, 2017

    Generic Skin Cream Buyers Fight Price-Fixing Row Dismissal

    Purchasers of generic medicated skin creams on Friday fought back against drugmakers’ anticipated attempts to dismiss four consolidated antitrust suits in New York federal court over alleged price-fixing, arguing that they’d done more than enough to show the plausibility of a conspiracy.

  • March 13, 2017

    Banks Ask 2nd Circ. To Keep ERISA Forex-Rigging Suit Dead

    Banks that were accused by thousands of retirees of violating the Employee Retirement Income Security Act after it was revealed that they manipulated key foreign exchange rates asked the Second Circuit on Friday not to resuscitate the would-be class action, saying the lower court had correctly concluded that the banks weren’t responsible for the retirement plans under that law.

  • March 13, 2017

    Retailers Seek Class Cert. In Card Chip Antitrust Suit

    A group of retailers has asked a California federal court to certify a class in a lawsuit alleging Visa, Mastercard, American Express and Discover conspired to unlawfully shift fraud liability to merchants, despite complications in switching to a new security chip system.

  • March 13, 2017

    Nixed $7.3B Antitrust Deal Unimpeachable, High Court Hears

    Retailers who support a scuttled $7.25 billion class action antitrust settlement with Visa and MasterCard over interchange fees have asked the U.S. Supreme Court to reject arguments that the Second Circuit decision vacating the deal should be left alone, saying the agreement’s importance cannot be refuted.

  • March 13, 2017

    City Scorns Secretive Review Of Economic Crime Agencies

    More details emerged Monday on the scope of the British government’s reappraisal of how it combats financial crime, amid criticism that the investigation's under-the-radar process doesn’t allow for input from law firms and financial services.

  • March 13, 2017

    EU Looks To Ease Gas Sales With Gazprom Antitrust Deal

    The European Union's antitrust regulator on Monday unveiled tentative agreements it has reached with Gazprom to unblock cross-border sales of gas in central and eastern Europe, saying the commitments by the Russian state-owned gas giant would address allegations that the company abused its dominance in the region.

  • March 13, 2017

    FDIC Sues Banks, BBA In UK Over Benchmarking

    The Federal Deposit Insurance Corporation filed proceedings against several banks, including Barclays PLC and Royal Bank of Scotland Group PLC, as well as the British Bankers Association at London’s High Court on Friday for matters relating to financial  benchmarking, according to the court register.

  • March 11, 2017

    Bharara Fired After Refusing To Resign

    U.S. Attorney Preet Bharara said on Saturday that he had been fired after he refused to comply with Attorney General Jeff Sessions' order directing Obama-appointed U.S. attorneys to resign.

  • March 10, 2017

    Big Banks Dodge Investors' Rate-Rigging Claims

    An investor suit accusing around 20 big banks and financial institutions of rigging interbank loan rates was tossed for lack of standing Friday by a New York federal judge who also trimmed claims and defendants in a related action.

  • March 10, 2017

    Mitsubishi Loses Bid To Exit Cathode Tube Price-Fixing MDL

    Mitsubishi Electric Corp. can’t get out of 13 cases in a multidistrict litigation accusing it of participating in a price-fixing conspiracy for cathode ray tubes, a California federal judge said Thursday in an order that’s still under seal.

  • March 10, 2017

    End-Payor Actions Consolidated In Propranolol Antitrust Row

    A New York federal judge Thursday consolidated two end-payer cases in a proposed class action alleging that drugmakers conspired to jack up the price of generic blood pressure medication propranolol, and rejected a motion for separate trials for cases filed by direct purchasers.

  • March 10, 2017

    US Chamber Again Sues Seattle Over Driver Unionization Law

    The U.S. Chamber of Commerce hit Seattle with another suit in Washington federal court on Thursday over the city’s law giving for-hire drivers working for companies like Uber and Lyft the right to unionize, calling the ordinance illegal, a conspiracy and an attack on competition within the ride-hailing industry.

  • March 10, 2017

    Developer Blasts Privileged-Doc Delay In Bid-Rigging Suit

    A developer alleging an illegal conspiracy to buy valuable parcels of land in Miami's financial district at a depressed price at bankruptcy auction told a Florida federal court Friday that a magistrate judge's refusal to rule on the merits of its bid to access opposing counsel Shutts & Bowen LLP's privileged documents has held up discovery.

  • March 10, 2017

    3rd Circ. Says State Univs. Subject To Some Antitrust Scrutiny

    The Third Circuit upheld a ruling Thursday that a Pennsylvania state university foundation could not face an antitrust suit over student housing policies under the state action doctrine, but rejected a finding that the school and its foundation were automatically immune.

Expert Analysis

  • Tracking Global Merger Control Changes For 2017

    Joshua Holian

    This year introduces new layers of complexity to the already challenging task of identifying which countries around the world will claim jurisdiction to review a given M&A transaction. Multiple jurisdictions are modifying their merger filing thresholds, and several other countries have newly introduced merger reporting requirements, say Joshua Holian and Amanda Reeves of Latham & Watkins LLP.

  • Prosecution Of Corporate Execs: The Latest Developments

    Dawn E. Murphy-Johnson

    During the last quarter of 2016, the U.S. Department of Justice announced several significant guilty pleas and indictments against corporate executives that may provide some clues about where the prosecution of executives is headed this year, say attorneys with Miller & Chevalier Chtd.

  • Opinion

    Love And Law In The Age Of Trump

    Kevin Curnin

    Love is not a subject that lawyers typically devote themselves to professionally. But as we witness this historic transition to a new administration, lawyers in particular are reminded that love is tied, however imperfectly, to our cherished founding ideals, says Kevin Curnin, president of the Association of Pro Bono Counsel.

  • An Update On Merger Filings In China

    Wei Huang

    In 2016, the law enforcement activities of China's Anti-Monopoly Bureau remained highly active — a record 378 transactions were filed, 360 transactions were placed on file, and 395 cases were closed. The agency's merger review has grown more efficient, say attorneys with Tian Yuan Law Firm.

  • The State Of The Litigation Finance Industry In 2017

    Christopher P. Bogart

    In the United States, the number of lawyers whose firms have used litigation finance has quadrupled since 2013. Even so, too many remain poorly informed, leaving them at a competitive disadvantage and prone to oddly persistent “alternative facts” about litigation finance, says Christopher Bogart, CEO of Burford Capital.

  • Major DOJ Antitrust Policy Shift On Immunity For Employees

    Cale A. Johnson

    A subtle change buried in the recent update to the U.S. Department of Justice Antitrust Division’s leniency guidance represents a significant policy shift that may have an impact on the effectiveness of internal investigations and what companies decide to do based on what they learn, say attorneys with Dykema Gossett PLLC.

  • 6 Ways To Get More From A Limited Budget For Trial Graphics


    With so many possibilities and variables, it can be difficult to adhere to a strict graphics budget when preparing effective visuals for trial. There are several things you can do to limit the cost of your visuals without sacrificing quality, says Marti Martin Robinson of Litigation Insights Inc.

  • What The Qualcomm Case Tells Us About FTC And FRAND

    Michael T. Renaud

    Federal Trade Commission staff will no doubt characterize its recent complaint against Qualcomm as the mere application of traditional antitrust principles to conduct that just happens to involve intellectual property licensing. If that were the case, then it should have been uncontroversial to include a discussion of these practices in the revised guidelines released four days earlier, say attorneys with Mintz Levin Cohn Ferris Gl... (continued)

  • 5 Things To Know About New DOJ-FTC Int'l Antitrust Guide

    Ethan E. Litwin

    The update to the U.S. Department of Justice and Federal Trade Commission guidelines for international antitrust enforcement reflects the agencies’ views on two critical issues that affect foreign entities — the scope of the extraterritorial application of U.S. antitrust law, and the circumstances under which comity concerns trump enforcement objectives, say Ethan Litwin and James Van Strander of Dechert LLP.

  • And Now A Word From The Panel: A Year Of Vanishing MDLs

    Alan Rothman

    2016 was a notable year for the Judicial Panel for Multidistrict Litigation: It created only 26 new MDL proceedings, a low-water mark for new MDL proceedings not seen in almost a quarter of a century. In this installment of his bimonthly series on the panel, Alan Rothman of Arnold & Porter Kaye Scholer LLP looks at the panel’s activity over the past year.